About this Course
This course is a recorded (home study version) of the 2024 CE Finale Encore Webinars.
Learning Objectives
Upon completion of this application based CE Activity, a pharmacist will be able to:
| Review the role of the Beers Criteria in reducing potentially inappropriate medication (PIM) use and enhancing patient safety in older adults |
| Identify recent updates to the Beers Criteria and their implications for medication management in geriatric care |
| Apply the updated Beers Criteria to real-world scenarios, optimizing medication selection and minimizing risks in older adults |
Release and Expiration Dates
Released: December 13, 2024
Expires: December 13, 2027
Course Fee
$17 Pharmacist
ACPE UAN
0009-0000-24-045-H05-P
Session Code
24RW45-XTY89
Accreditation Hours
1.0 hours of CE
Additional Information
How to Complete Evaluation: When you are ready to submit quiz answers, go to the BLUE take test/evaluation button. Don't forget to use the session code above, or that was sent to you in your confirmation email NOT the one on the presentation!
Accreditation Statement
| The University of Connecticut School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. |  |
Pharmacists and Pharmacy Technicians are eligible to participate in this application-based activity and will receive up to 1.0 CE Hours (or 0.1 CEUs) for completing the activity ACPE UAN 0009-0000-24-045-H05-P, passing the quiz with a grade of 70% or better, and completing an online evaluation. Statements of credit are available via the CPE Monitor online system and your participation will be recorded with CPE Monitor within 72 hours of submission.
Grant Funding
There is no grant funding for this activity.
Faculty
Kelsey Giara, PharmD
Freelance Medical Writer
Adjunct Faculty
University of Connecticut School of Pharmacy
Pelham, NH
Faculty Disclosure
In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity.
- Dr. Giara has no financial relationships with ineligible companies.
Disclaimer
The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.
Content
Handouts
Post Test
Learning Objectives
• Review the role of the Beers Criteria in reducing potentially inappropriate medication (PIM) use and enhancing patient safety in older adults
• Identify recent updates to the Beers Criteria and their implications for medication management in geriatric care
• Apply the updated Beers Criteria to real-world scenarios, optimizing medication selection and minimizing risks in older adults
1. About how many older adults are prescribed potentially inappropriate medications?
A. One in seven
B. One in five
C. One in three
2. Which of the following describes how age-related physiologic changes affect older adults?
A. Decreased renal and hepatic blood flow slows drug excretion, causing toxicity
B. Frailty increases activity in drug metabolizing pathways, making drugs less effective
C. Decreased body fat and dehydration affect drug distribution and cause toxicity
3. Which of the following best describes a potentially inappropriate medication?
A. A drug that is contraindicated in patients older than 65 years
B. A drug for which risks outweigh benefits in older adults
C. A drug that should only be used in hospice or end-of-life care
4. Which of the following is TRUE?
A. Older adults should always avoid SGLT2 inhibitors
B. The updated criteria removes doxepin < 6 mg/day
C. Dabigatran is the safest anticoagulant for older adults
5. Which of the following best describes Beers Criteria guidance on proton pump inhibitors (PPIs)?
A. Deprescribe after 8 weeks of scheduled use, unless the patient is high-risk
B. After 8 weeks of scheduled use, reevaluate risks and benefits and continue if tolerated
C. Avoid scheduled use completely and advise patients to use intermittent antacids
6. Which of the following is a reason to deprescribe a medication found on the Beers Criteria?
A. The drug is being used to treat cancer but carries a risk of acid reflux
B. The drug is being used to treat two indications at once
C. The drug was prescribed to address the adverse effect of another drug
7. Mrs. Taylor, a 78-year-old woman with a history of AFib and diabetes, is prescribed rivaroxaban for stroke prevention and glyburide for glycemic control. During a consultation, she reports episodes of dizziness and has a recent lab result showing a creatinine clearance of 35 mL/min. Which of the following is the BEST plan of action?
A. Recommend switching glyburide to glipizide
B. Advise switching rivaroxaban to warfarin
C. Continue both medications with increased monitoring for AEs
VIDEO